Shahla Jaleel

IL-22: a promising candidate to inhibit viral-induced liver disease progression and hepatocellular carcinoma

S. Manzoor, M. Saalim, Saleha Resham, 2015, Tumor Biology.

Mechanistic study of the interaction between IL-22 and HCV core protein in the development of hepatocellular carcinoma among liver transplant recipients.

S. Manzoor, M. Saalim, Saleha Resham, 2020, Microbial pathogenesis.

Purinoceptor expression in hepatocellular virus (HCV)-induced and non-HCV hepatocellular carcinoma: an insight into the proviral role of the P2X4 receptor

A. Asif, S. Manzoor, M. Khalid, 2018, Molecular Biology Reports.

IL-22 in hepatocyte’s survival of Pakistani patients with end stage liver disease: an insight into IL 22 mediated hepato-regenerative pathway

A. Latif, S. Manzoor, M. Saalim, 2019, Molecular Biology Reports.

Purinoceptor expression in hepatocellular virus (HCV)-induced and non-HCV hepatocellular carcinoma: an insight into the proviral role of the P2X4 receptor

A. Asif, S. Manzoor, M. Khalid, 2018, Molecular Biology Reports.

IL-22 in hepatocyte’s survival of Pakistani patients with end stage liver disease: an insight into IL 22 mediated hepato-regenerative pathway

A. Latif, S. Manzoor, M. Saalim, 2019, Molecular Biology Reports.